TrialJournal of affective disorders2015

Shank3 as a potential biomarker of antidepressant response to ketamine and its neural correlates in bipolar depression.

Robin Ortiz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.